Autoimmune bullous disorders (AIBDs) are a heterogeneous group of rare diseases clinically characterized by erosions and/or blisters on the skin and mucous membranes. AIBDs can be categorized into two groups: pemphigus diseases, characterized by intraepidermal blistering and autoantibodies against desmosomal proteins such as desmoglein (Dsg) 1, Dsg3, members of the plakin family, and subepidermal AIBDs, comprised of pemphigoid diseases and dermatitis herpetiformis. Autoantibodies in dermatitis herpetiformis target transglutaminases 2 and 3, while in pemphigoid disease, autoantibodies are directed against structural proteins of the dermal-epidermal junction. Although analysis of a perilesional biopsy with direct immunofluorescence (IF) microscopy is still the diagnostic gold standard, several assays have become widely available that allow serological diagnosis in the majority of patients. Standard serological diagnosis includes indirect IF on monkey esophagus and salt-split human skin. Assays to further characterize autoantibody specificity include ELISA systems based on recombinant forms of the immunodominant regions of the target antigens as well as multivariant indirect IF microscopy tests with several miniature substrates. These serological assays are complemented by various in-house assays using immunoblotting and ELISA, which are only available in specialized laboratories. Here we review new developments in the diagnosis of AIBDs and describe state-of-the-art diagnostic procedures for this group of diseases.
Introduction
Autoimmune bullous diseases (AIBDs) are a heterogeneous group of disorders defined by autoantibodies against adhesion molecules of the skin and superficial mucous membranes. Depending on the targeted structures, AIBDs can be grouped into pemphigus diseases with autoantibodies against desmosomal adhesion molecules, pemphigoid diseases with autoantibodies against structural proteins of the dermal-epidermal junction, and dermatitis herpetiformis, where epidermal and/ or tissue transglutaminase are targeted [1] [2] [3] [4] . In pemphigus diseases, binding of autoantibodies leads to loss of adhesion between keratinocytes, with intra-epidermal split formation resulting in a flaccid blister or erosion [4, 5] . In pemphigus vulgaris with only mucous membrane lesions, autoantibodies are restricted to desmoglein (Dsg) 3, while in pemphigus vulgaris patients with both mucosal and skin lesions, autoantibodies against both Dsg3 and Dsg1 are present. Patients with pemphigus foliaceus only generate autoantibodies against Dsg1 [4, 5] . By contrast, autoreactivity in paraneoplastic pemphigus is more diverse, including T cell-mediated pathology and at least 10 different target antigens, most frequently Dsg3 and proteins of the plakin family (Table 1, Figure 1 ) [6, 7] .
In pemphigoid diseases, autoantibodies attach along the dermal-epidermal junction and induce subepidermal blistering, which manifests clinically as tense blisters. Depending on the target antigen and the clinical presentation, pemphigoid diseases are subdivided into bullous pemphigoid (BP), mucous membrane pemphigoid (MMP), anti-p200/laminin-γ1 pemphigoid, pemphigoid gestationis (PG), linear IgA disease, and epidermolysis bullosa acquisita [1, 8] (Table 1 , Figure 1 ). The incidence of AIBDs varies substantially, depending on ethnicity and geographical region [9] [10] [11] [12] . In Northern and Central Europe as well as North America, the most common entity is BP with incidences between 13 and 42/million/year [9, 15] . Recently, the prevalence of BP in Germany was calculated to be 21,000 patients (127/million inhabitants) [16] . For MMP, incidences of 2.0/ million/year and prevalences of 12.0 patients/million were reported, and for PG prevalences of 12.6 patients/million females were described [13, 16] . Pemphigus diseases are much rarer in Northern and Central Europe, with incidences ranging from 0.8 to 7/million/year for pemphigus vulgaris and about 10 times less for pemphigus foliaceus. Prevalences in Germany were estimated as 48 patients/million for pemphigus vulgaris and 4.6 patients/million for pemphigus foliaceus [10, [16] [17] [18] . Higher incidences for pemphigus are found in Ashkenazi Jews and in the Iranian population [19] . Diagnosis of AIBDs is based on clinical features and the detection of skin/mucous membrane-bound and circulating autoantibodies. Precise identification of the individual disease entity is essential for both prognosis and selection of the therapeutic approach. For example, anti-laminin 332 MMP has been associated with solid malignancies in up to 30 % of patients [20] . Other examples include paraneoplastic pemphigus that is always associated with a neoplasia [6, 7] , epidermolysis bullosa acquisita that usually requires more intensive treatment than BP, whereas patients with anti-p200/laminin γ1 pemphigoid can often be controlled with less immunosuppression [1, 21] . Serological analyses are crucial for the diagnosis of anti-laminin 332 MMP, anti-p200/laminin γ1 pemphigoid and paraneoplastic pemphigus. In addition to their use in diagnosis, serological assays are also very valuable during the course of the disease, since with pemphigus, BP, and epidermolysis bullosa acquisita, serum autoantibodies against Dsg1 and 3 as well as type VII and XVII (BP180) collagen correlate with disease activity and can thus be used to guide treatment decisions, such as reduction of prednisolone doses when lesions have almost or completely healed [22] [23] [24] [25] [26] [27] . Accordingly, recent guidelines of the German Dermatological Society for the diagnosis and treatment of BP and pemphigus recommend regular measurement of serum autoantibodies during the follow-up of these patients [22, 24] .
So far, various assays and techniques have been developed to detect autoantibodies in AIBDs, and this has led to a great improvement in diagnosis during the last decade. An increasing number of tests has become widely available, although some are primarily performed in specialized centers [28] . Here we review recent developments in the diagnosis of AIBDs, focusing on direct IF microscopy and serology.
Clinical features relevant for diagnosis
In pemphigus vulgaris, superficial mucous membranes are always affected, most frequently in the oral cavity (Figure 2a ). About half of pemphigus vulgaris patients also develop skin lesions, usually flaccid blisters, erosions, and crusts. Lesions are frequently painful and may lead to impairment of food intake. In pemphigus foliaceus, lesions are restricted to the skin and present with crusts and erosions, predominantly in the seborrheic areas (Figure 2c ) [4, 29] . In pemphigus (but not in pemphigoid diseases), tangential pressure on normal-looking skin can provoke erosions, a phenomenon known as the Nikolsky sign. Characteristic for paraneoplastic pemphigus is severe stomatitis, which frequently involves the lips, and other heterogeneous lesions including flaccid blisters, erosions, pustules, lichenoid dermatitis, and erythema multiforme-like lesions. Paraneoplastic pemphigus is always associated with neoplasia (most frequently hematological malignancies), thymoma, and Castleman's disease in China and Japan [6, 30, 31] . Pemphigoid diseases usually present with tense blisters (Figure 2e ) and may be difficult to distinguish from one another clinically. In BP, the advanced age at disease onset (77 and 83 years in Central Europe, Scandinavia, and the UK [9, 10, 15, 16, 32] ) and severe itching are suggestive [19, 33, 34] . In the premonitory stage and in about 20 % of BP patients in the remaining course of the disease, tense blisters and erosions are lacking and patients present with a large variety of skin lesions such as erythema, urticarial plaques, eczema, prurigo simplex, pruritic nodules or pruritus sine materia [1, 34, 35] . PG only occurs during pregnancy and the postpartum period, and presents with pruritus and urticarial erythema that usually starts in the periumbilical region [36] . Blisters are frequently absent. For the diagnosis of MMP, predominant mucosal involvement is required; oral, ocular, and nasal mucosa are most frequently affected, but the larynx, esophagus and genitalia may be involved [37] . In about 20-30 % of cases, cutaneous blisters and erosions as well as mucosal lesions develop [1, 37] . Lesions in MMP usually heal with scarring, with the exception of those in the oral cavity. This may lead to impaired vision or even blindness as well as esophageal and laryngeal strictures [1, 2, 20] . By contrast, linear IgA disease most frequently affects children and infants [38] [39] [40] . Lesions with vesicles at their periphery, so-called "rings of jewels" or "strings of pearls", are common but not pathognomonic [41, 42] . Urticarial plaques and blisters can also be present, and mucosal involvement can be seen in 60-70 % of patients [41] . Patients with anti-p200/ laminin γ1 pemphigoid are younger than those with BP (mean age of 72 years). The palmar and plantar areas are often involved, and in Japan the disease is frequently associated with psoriasis [21] . In the classic/mechanobullous form of epidermolysis bullosa acquisita, lesions appear predominantly on traumatized skin and heal with scars resembling hereditary dystrophic epidermolysis bullosa, while the inflammatory subtype resembles BP and MMP. In both subtypes, involvement of mucous membranes occurs in about 50 % of patients [1, 43] . Dermatitis herpetiformis, the cutaneous manifestation of coeliac disease, is clinically characterized by itchy papules and vesicles, predominantly on the gluteal area and posterior aspects of the arms and legs [44, 45] .
Histopathology
Histopathology of a lesional skin biopsy may be the first step in differentiating between pemphigus and subepidermal blistering diseases [46] (Figure 2b, d, f) . Further investigations may be advisable, particularly in the routine diagnosis of AIBDs. These include direct IF microscopy and serology if symptoms are consistent with AIBD, in paraneoplastic pemphigus (acantholysis, dyskeratosis, vacuolar degeneration of the basement membrane zone, lichenoid infiltrates in the upper dermis), and finally, for differential diagnoses when an AIBD could not be diagnosed after an appropriate workup. Various studies have evaluated the visualization of immunoglobulins and C3d/C4d in paraffin-embedded lesional biopsies. The results to date have shown significantly lower sensitivity and specificity than for direct IF microscopy of perilesional biopsies [47] [48] [49] [50] .
Optical coherence tomography and in-vivo confocal laser microscopy are non-invasive methods that can determine the level of split formation, but they have not yet been routinely applied in the diagnosis of AIBDs [51, 52] .
Direct immunofluorescence microscopy
Despite various advances in serological diagnosis of AIBDs (see below), direct IF microscopy of a perilesional biopsy is still the diagnostic gold standard, with a specificity of 98 % and sensitivities ranging from 82-91 % [53, 54] . However, it is essential to take the biopsy from perilesional skin to ensure that the dermal-epidermal junction is intact in order to fully assess immunoglobulin and complement deposition along this structure [24, 55, 56] . In lesional skin, adhesion proteins may have already been degraded, resulting in false negative or false positive results. With direct IF, intercellular intra-epidermal/epithelial staining of IgG (IgA in the rare IgA pemphigus variant) and/or C3 is seen in pemphigus diseases, while in pemphigoid diseases, linear staining along the dermal-epidermal junction is diagnostic [55, 56] (Figure 3) . The basement membrane of adnexal structures may also be stained [57] . In dermatitis herpetiformis, granular IgA deposits are present in dermal papillae and along the dermal-epidermal junction [55, 58] . In paraneoplastic pemphigus, direct IF microscopy may reveal a combined pattern of intercellular epithelial and basement membrane staining [6] .
To differentiate between some of the pemphigoid diseases, an artificial split can be induced within the lamina lucida of the basement membrane zone by incubation of the biopsy specimen in 1 M NaCl solution. Antibodies against laminin 332, the p200 antigen/laminin γ1, and type VII collagen bind at the floor of the artificial blister, while antibodies against BP180, BP230 (dystonin-e), and α6β4 integrin bind along the roof of the blister [8, 59] . Jonkman and coworkers used a more elegant method without destroying the biopsy, and reported two linear and somewhat undulatory patterns in pemphigoid diseases. The "u-serrated" pattern has arches closed at the bottom and an appearance like "growing grass"; this is pathognomonic for binding of antibodies against type VII collagen in epidermolysis bullosa acquisita and the rare cases of bullous systemic lupus erythematosus. The "n-serrated" pattern has arches closed at the top, and is found in all other pemphigoid diseases (Figure 3 ) [60] [61] [62] . Recent studies showed that pattern diagnosis is easy to learn (an online training program is available at www.nversusu. umcg.nl [61] ), has high inter-observer conformity, and can be performed using 4 μm or 6 μm sections and a magnification of 400-fold [60, 61] .
Indirect Immunofluorescence microscopy
Indirect IF microscopy of organ substrates visualizes circulating autoantibodies against desmosomal antigens and antigens of the dermal-epidermal junction. For pemphigus diseases, monkey or guinea pig esophagus is the most sensitive substrate for detection of intercellular staining in the epithelium [63, 64] (Figure 4a ). In dermatitis herpetiformis, IgA reactivity is seen with endomysium [65] . In pemphigoid diseases, autoantibodies reveal linear staining at the dermal-epidermal junction with esophagus sections (Figure 4b ). To further discriminate pemphigoid diseases, 1 M NaCl-split human skin has proven to be the most sensitive screening substrate, with a sensitivity of 75-95 % and a specificity of 98-100 % [53, 54, 66, 67] . Autoantibodies against BP180, BP230, and α6β4 integrin bind to the blister roof ( Figure  4c ), while autoantibodies against laminin 332, laminin γ1, the p200 antigen, and type VII collagen stain the blister floor (Figure 4d ). Figure 3 Direct immunofluorescence microscopy in pemphigoid diseases. Linear fluorescence along the basement membrane of a perilesional skin biopsy in a patient with bullous pemphigoid showing an n-pattern (a) and with epidermolysis bullosa acquisita displaying a u-pattern (b). The n-pattern is characterized by arches closed at the top, while the u-pattern has arches closed at the bottom with an appearance of "growing grass". The u-pattern is only seen in patients with reactivity against type VII collagen, i.e. in epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. To identify autoantibodies against plakins in suspected paraneoplastic pemphigus, both rat and monkey bladder can be used due to their plakin-rich urothelia [68] . In PG, autoantibodies along the dermal-epidermal junction can best be visualized after pre-incubation of salt-split skin with a complement source, since the predominant autoantibodies belong to the IgG1 and IgG3 subclasses, and therefore have high complement-fixing activity [69] . This approach may also be applied in BP with a sensitivity of about 70 % [70] . The use of rabbit esophagus for the detection of AIBD autoantibodies has also been reported [53] .
Recently established indirect IF tests, referred to as BIO-CHIP ® mosaics, employ a human cell line that recombinantly expresses target antigens on the cell surfaces; these tests are discussed below.
Enzyme-linked immunosorbent assay (ELISA)
A variety of highly sensitive and specific ELISA systems has become commercially available within the last two decades. These ELISAs not only allow one to identify autoantibodies against specific autoantigens; they also make it possible to quantify serum autoantibody levels. For pemphigus, ELISAs are based on the ectodomains of Dsg1 and Dsg3, recombinantly expressed by baculovirus (MBL, Nagoya, Japan), or HEK293 cells (Euroimmun, Lübeck, Germany) [27, 71, 72] . These ELISAs are also valuable tools for monitoring the course of disease activity [27, 72] . An ELI-SA for autoantibodies against envoplakin in paraneoplastic pemphigus has recently been developed (EUROIMMUN) [73] . For pemphigoid diseases, ELISAs applying recombinant BP180 NC16A, BP230, and type VII collagen are commercially available (MBL, Euroimmun) [23, [74] [75] [76] [77] . The BP180 NC16A ELISA yielded diagnostic sensitivities between 84 % and 89 % with BP [75, 76, 78] and from 96 % to 97 % in pemphigoid gestationis [79, 80] . For BP, additional use of the BP230 ELISA increases the diagnostic sensitivity by about 5-8 % [81, 82] . ELISA for IgG and IgA antibodies against coeliac-specific portions of gliadin autoantibodies as well as transglutaminase 2 and 3 have facilitated the serological diagnosis of dermatitis herpetiformis [45, 83] .
Various other ELISAs have been reported, including those for detection of IgE antibodies against BP180 NC16A [26, [84] [85] [86] and for detection of serum reactivity against desmocollins [87, 88] , laminin γ1 [89] , the ectodomain of BP180 [90] , full-length BP180 [91] , laminin 332 [92, 93] , and various other forms of BP180 [94] [95] [96] . Some recent ELISA systems have not yet been standardized and are only available in specialized laboratories.
Multivariant assays
Several multivariant assays are available to facilitate and accelerate the diagnostic process; these offer a single step multivariant diagnostic tool for the majority of AIBDs. These serological assays are either ELISAs or IF-based. The first multivariant assay for the diagnosis of AIBDs involved indirect IF microscopy and BIOCHIP ® technology. Here, a standard-sized laboratory slide is employed with different incubation fields ( Figure 5 ). Within an incubation field, there are miniature biochips coated with different substrates, e.g. monkey esophagus, salt-split skin, recombinant BP180 NC16A (the immunodominant region for BP and PG) or HEK293 cells recombinantly expressing Dsg1, Dsg3, or BP230 on their cell surfaces. We have recently shown that this BIOCHIP ® mosaic enables serological diagnosis of AIBDs in about 94 % of cases, with high comparability to ELISA results for pemphigus and pemphigoid disorders [97] . This technology has since been applied worldwide in various routine laboratories [98] [99] [100] .
Recently, a mosaic comprising four biochips (recombinant BP180 NC16A, HEK cells expressing BP230, salt-split skin, and monkey esophagus) was used to detect autoantibodies in 100 % of PG sera [36] . A BIOCHIP ® mosaic including the immunodominant NC1 domain of type VII collagen has yielded sensitivities of 92 % and 100 % [77, 101] . These data show that this BIOCHIP ® mosaic is a valuable tool for routine diagnosis of PG and epidermolysis bullosa acquisita. Interestingly, when a BIOCHIP ® mosaic containing recombinant forms of desmocollin 1, 2, and 3 was tested with various cohorts of more than 400 pemphigus sera, anti-desmocollin IgG and/or IgA reactivity was only found in about 3 % of pemphigus patients [102] (Figure 5 ). According to the guidelines of the German Dermatological Society, analysis for anti-desmocollin reactivity may only be recommended in patients with IgA pemphigus, pemphigus vegetans, atypical pemphigus, and for rare patients with pemphigus vulgaris/ foliaceus without anti-Dsg reactivity [24] .
Meanwhile, the BIOCHIP ® mosaic has been further extended with rat bladder (for detection of plakin-specific antibodies in paraneoplastic pemphigus) and recombinant coeliac-specific portions of gliadin (for detection of anti-endomysium reactivity) comprising 10 different substrates ( Figure 6 ) [103] . This extended BIOCHIP ® mosaic was applied very recently in a cohort of 749 AIBD sera from patients with positive direct IF microscopy, and detected AIBD-specific autoantibodies in 98.8 % of pemphigus cases and 96.6 % of subepidermal AIBD cases [103] .
With the same technology, the application of recombinant forms of laminin 332 yielded sensitivities between 75 % and 85 % with a specificity of nearly 100 % [104] (Figure  7 ). When this test becomes available, it may be a major step forward in the diagnosis of anti-laminin 332 MMP; thorough investigations for malignancy should be suggested in reactive patients.
Another approach to simplifying and accelerating the diagnosis of AIBDs has been made possible by the development of two ELISA-based multivariant assays. They allow simultaneous testing of BP180, BP230, Dsg1, Dsg3, type VII collagen (MESACUP anti-skin profile, MBL) and of additional envoplakin (Dermatology Profile ELISA, Euroimmun) in a single serum sample in one row of an ELISA plate. Both multivariant assays have been successfully applied in the routine diagnosis of AIBDs, and revealed high concordance with single test analyses in 88 % and 87 % of the results [105, 106] . In an experimental setup, the Immuno Solid-Phase Allergen Chip (ISAC) microarray (Thermo Fischer Scientific Phadia AB, Uppsala, Sweden) has been shown to simultaneously detect IgE and IgG antibodies against BP180 NC16A, replicating corresponding ELISA values [107] .
Immunoblot and immunoprecipitation
For detection of autoantibodies against some target antigens and antigenic regions such as the p200 protein ( Figure  8c ), laminin γ1 (Figure 8b ), C-terminal stretches of BP180, the soluble ectodomain of BP180 (LAD-1) (Figure 8a) , as well as cell-derived forms of envoplakin, periplakin, desmoplakin, BP180, BP230, α4β6 integrin, laminin 332, and type VII collagen (Figure 8c ), tests are only available in specialized laboratories using immunoblotting, immunoprecipitation or indirect IF microscopy with skin sections from epidermolysis bullosa patients deficient for a specific antigen, e.g. type VII collagen or laminin 332 [108] . These test systems are also used to measure IgA autoantibodies. For immunoblotting and immunoprecipitation, recombinant proteins or various extracts of dermis, epidermis, bovine gingiva, amnion membrane, and cultured keratinocytes are applied [7, [109] [110] [111] [112] [113] [114] [115] [116] .
Diagnostic pathways
Diagnostic pathways for BP, pemphigus vulgaris, and pemphigus foliaceus are highlighted in the Sk2 guideline of the German Dermatological Society. Diagnosis of anti-p200/ Figure 6 BIOCHIP ® mosaic for multivariant diagnostic tests of the most frequent autoimmune bullous diseases. Each field contains ten different substrates on a standard-sized laboratory slide with ten incubation fields (see Figure 5 ). Here, representative staining of various sera (bullous pemphigoid, epidermolysis bullosa acquisita, pemphigus vulgaris, paraneoplastic pemphigus) with different BIOCHIPs ® is shown. Reactivities with monkey esophagus (basement membrane zone), primate salt-split skin (epidermal side), rat bladder (urothelium staining), human HEK293 cells expressing recombinant proteins, i.e. type VII collagen, BP230, desmoglein 1, and desmoglein 3 as well as recombinant BP180 NC16A (spotted in diamond-shape) and gliadin GAF 3x (spotted in dots) are shown. HEK293 cells transfected with pTriEx-1 served as negative controls (EU90) [103] (courtesy of Stine Krüger, Lübeck). 4) with extract of human dermis shows IgG4 reactivity against type VII collagen (upper arrow) and p200 antigen (lower arrow). Lane 1, healthy volunteer (c).
laminin γ1 pemphigoid, MMP and epidermolysis bullosa acquisita (including schematic diagrams) is detailed in recent publications [21, 43, [117] [118] [119] . Briefly, in a patient with suspected AIBD, we recommend a perilesional biopsy for direct IF microscopy and a lesional biopsy for histology. Sensitive and specific screening tests for serum autoantibodies are human salt-split skin (for pemphigoid diseases) and monkey esophagus (for both pemphigus and pemphigoid diseases). Subsequent serological analyses are required for the exact diagnosis and (depending on the technical equipment, experience, and preference of a given laboratory) involve multivariant IF microscopy (BIOCHIP ® mosaic), ELISA systems or a classic multistep approach including individual ELISA and/or immunoblot tests.
Conclusion
Exact diagnosis of AIBDs is essential for both prognosis and treatment decisions. Current diagnosis of AIBDs is based on the clinical picture, histopathology of a lesional biopsy, direct IF microscopy of a perilesional biopsy, and serology. Pattern analysis of direct IF microscopy samples from pemphigoid patients now allows the differentiation of patients with epidermolysis bullosa acquisita from other pemphigoid disorders. The fastest-developing field is certainly serological diagnosis of AIBDs. Commercial assays, ELISA and indirect IF-based assays have been established, using recombinant forms of six target antigens (Dsg1, Dsg3, envoplakin, BP180 NC16A, BP230, and type VII collagen, with laminin 332 soon to follow). In addition to assays using single antigens, multivariant ELISA and BIOCHIP ® mosaic-based indirect IF tests are available. These tests do not include all epitopes of the molecules and not all target antigens, but a number of in-house tests based on ELISA, immunoblotting, and immunoprecipitation are available in specialized laboratories [97] . A few laboratories have successfully obtained formal accreditation, e.g. by the German Accreditation Body (DAkkS), including the autoimmune laboratory of the Department of Dermatology, University of Lübeck (DAkkS D-ML-13069-06-00), which offers the entire diagnostic spectrum for AIBDs (www.derma.uni-luebeck.de/autoimmunlabor). Future developments are aimed at establishing test systems for antibodies against additional target antigens, and will focus on automatization and novel technologies that provide highly reliable and standardized multivariant diagnostics for AIBDs.
